The aim of our research was to investigate the potential prognostic role of non-specific laboratory parameters at admission, as well as baseline serum levels of MMP-2 and MMP-9 in predicting the risk of hemorrhagic transformation, discharge outcomes, and the 3-month follow-up status of patients with ischemic stroke. The gene discussed is MMP9; the disease is ischemic stroke.